(Q33361279)

26 July 2017

1 reference

title

Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials (English)

1 reference

26 July 2017

1 reference

1 reference

Stanworth SJ

1

1 reference

26 July 2017

Brunskill SJ

2

1 reference

26 July 2017

Hyde CJ

3

1 reference

26 July 2017

McClelland DB

4

1 reference

26 July 2017

Murphy MF

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

British Journal of Haematology

26 July 2017

1 reference

26 July 2017

126

1 reference

26 July 2017

1

1 reference

26 July 2017

139-152

1 reference

Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Which clinical studies provide the best evidence? The best RCT still trumps the best observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Cardiac bypass haemostasis: putting blood through the mill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

The concentration of plasma fibronectin in burns patients treated with fresh frozen plasma or plasma protein fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Correcting prolonged bleeding during renal transplantation with estrogen or plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Effects of different plasma substitutes on blood coagulation: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Extracellular volume in preterm infants: influence of gestational age and colloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Renal function in preterm infants during the first five days of life: influence of maturation and early colloid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Clinical use of FFP: results of a retrospective process and outcome audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Risks associated with transfusion of cellular blood components in canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

The management of coumarin-induced over-anticoagulation Annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

A randomized controlled trial oftransfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Viral inactivation of fresh frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Guidelines for assessing appropriateness of pediatric transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. PRODROMI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

A review of randomized controlled trials using therapeutic apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04973.X

Preoperative plasmapheresis in patients undergoing cardiac surgery procedures

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/00000542-199002000-00013

Identifiers

DOI

10.1111/J.1365-2141.2004.04973.X

1 reference

26 July 2017

1 reference